$NCDL Balance Sheet | Understand Stock

$NCDL

$10.82 +$0.33 (3.15%) Live

$NCDL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of assets and liabilities

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023
Assets
Investments
Non-controlled/non-affiliated company investments, at fair value (amortized cost of $1,510,014 and $1,225,573, respectively)
Non-controlled/Non-affiliated
Total non-controlled/non-affiliated company investments, at fair value (amortized cost of $1,510,014 and $1,225,573, respectively)
Non-controlled/non-affiliated company investments, at fair value (cost of $1,971,534 and $2,001,207, respectively)
Non-controlled/Non-affiliated
Total non-controlled/non-affiliated company investments, at fair value (cost of $1,971,534 and $2,001,207, respectively)
Cash and cash equivalents
Cash
Cash equivalents
Total cash and cash equivalents
Restricted cash
Due from adviser expense support (See Note 4)
Due from adviser expense support (See Note 5)
Interest receivable
Derivative asset, at fair value (Note 4)
Receivable for investments sold
Contribution receivable
Prepaid expenses
Other assets
Total assets

Liabilities
Debt (net of $8,005 and $8,511 deferred financing and issuance costs, respectively, and net of unamortized discount of $415 and $471, respectively) (See Note 7)
Payable for investments purchased
Interest payable
Due to adviser expense support (See Note 4)
Due to adviser for expense support (See Note 5)
Incentive fees payable
Management fees payable
Collateral due to broker
Distributions payable
Directors’ fees payable
Accounts payable and accrued expenses
Total liabilities

Net Assets: (See Note 9)
Common shares, $0.01 par value, 500,000,000 and 500,000,000 shares authorized, 49,387,065 and 49,387,065 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Paid-in-capital in excess of par value
Total distributable earnings (loss)
Total net assets
Total liabilities and net assets
Net asset value per share (in dollars per share)

Comments